FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Celsion Presents Compelling Data at AACR 2016 Demonstrating Synergistic Anti-Cancer Effect of GEN-1 IL-12 Immunotherapy Plus Avastin® and Doxil®
April 19, 2016
Celsion Announces Upcoming Presentation at AACR 2016 Highlighting Potential of GEN-1 IL-12 Immunotherapy in Ovarian Cancer
April 12, 2016
Celsion Corporation Reports Year End 2015 Financial Results and Provides Business Update
March 30, 2016
Celsion Corporation to Hold Year-End 2015 Financial Results Conference Call on Wednesday, March 30, 2016
March 23, 2016
Celsion Announces Presentation of Preclinical Data for GEN-1 IL-12 Immunotherapy in Combination with Avastin® and Doxil® at the AACR Annual Meeting 2016
March 16, 2016
Celsion Corporation Announces Issuance of Key U.S. Patent Covering its Novel TheraSilence™ RNA Program
March 01, 2016
Celsion Corporation Highlights Recent Pipeline Developments for its GEN-1 Immunotherapy Program and Provides Business Update
February 12, 2016
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here